Zoe Johnson BSc, PhD

Zoe holds a PhD in Pharmacology from King’s College London, UK. Zoe has more than 15 years of experience in the biopharmaceutical industry in the UK and Europe where she has worked across a range of therapy areas including oncology, autoimmune & inflammatory diseases and allergy. Her main area of expertise is in building preclinical pharmacology packages to support IND filings, as well as providing bioanalytical support to late-stage clinical development programs. Zoe is an experienced project leader and has successfully led both small and large molecule projects through late-stage preclinical development. Zoe has previously worked at UCB, Merck and Novimmune and is based in Geneva, Switzerland.